Skip to main content

Table 2 Associations between TyG index and its combination with obesity indicators and breast cancer risk among postmenopausal women in UK Biobank (n = 83,873)

From: Association between triglyceride-glucose related indicators, genetic risk, and incident breast cancer among postmenopausal women in UK Biobank

 

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Per 1-SD increase

P for trend

TyG

 Median

8.03

8.42

8.75

9.20

  

 No. of cases/person-years

838/279,674

891/278,915

878/278,589

954/278,128

  

Model 1, HR (95% CI)

1.00

1.06 (0.96–1.16)

1.04 (0.95–1.14)

1.13 (1.03–1.24)

1.04 (1.00–1.07)

0.017

Model 2, HR (95% CI)

1.00

1.06 (0.96–1.16)

1.04 (0.95–1.14)

1.13 (1.03–1.24)

1.04 (1.00–1.07)

0.019

Model 3, HR (95% CI)

1.00

1.06 (0.96–1.16)

1.04 (0.94–1.15)

1.12 (1.01–1.25)

1.03 (0.99–1.08)

0.059

TyG-WC

 Median

606.3

681.04

750.74

860.56

  

 No. of cases/person-years

727/278,955

905/279,921

918/278,975

1011/277,455

  

Model 1, HR (95% CI)

1.00

1.22 (1.11–1.35)

1.24 (1.12–1.36)

1.37 (1.24–1.50)

1.10 (1.07–1.14)

 < 0.001

Model 2, HR (95% CI)

1.00

1.22 (1.11–1.35)

1.23 (1.12–1.36)

1.36 (1.23–1.49)

1.10 (1.06–1.13)

 < 0.001

Model 3, HR (95% CI)

1.00

1.22 (1.11–1.35)

1.23 (1.12–1.36)

1.35 (1.23–1.49)

1.10 (1.06–1.14)

 < 0.001

TyG-WHtR

 Median

3.73

4.20

4.64

5.33

  

 No. of cases/person-years

786/279,386

853/279,531

922/279,085

1000/277,307

  

Model 1, HR (95% CI)

1.00

1.05 (0.95–1.15)

1.09 (0.99–1.20)

1.17 (1.06–1.28)

1.05 (1.02–1.08)

 < 0.001

Model 2, HR (95% CI)

1.00

1.05 (0.95–1.15)

1.09 (0.99–1.20)

1.16 (1.06–1.28)

1.05 (1.01–1.08)

 < 0.001

Model 3, HR (95% CI)

1.00

1.05 (0.95–1.15)

1.09 (0.99–1.20)

1.16 (1.05–1.28)

1.05 (1.01–1.08)

 < 0.001

TyG-WHR

 Median

6.22

6.76

7.23

7.88

  

 No. of cases/person-years

815/280,358

867/279,793

908/278,957

971/276,199

  

Model 1, HR (95% CI)

1.00

1.05(0.96–1.14)

1.08(0.99–1.17)

1.21(1.11–1.31)

1.06(1.03–1.10)

0.001

Model 2, HR (95% CI)

1.00

1.04(0.96–1.14)

1.08(0.99–1.18)

1.22(1.12–1.32)

1.07(1.04–1.10)

0.001

Model 3, HR (95% CI)

1.00

1.04(0.96–1.14)

1.08(0.99–1.18)

1.22(1.12–1.33)

1.07(1.03–1.10)

0.003

TyG-BMI

 Median

187.23

213.12

238.40

282.69

  

 No. of cases/person-years

765/278,469

880/279,486

894/278,896

1022/278,456

  

Model 1, HR (95% CI)

1.00

1.14 (1.03–1.25)

1.15 (1.04–1.26)

1.32 (1.20–1.45)

1.10 (1.06–1.13)

 < 0.001

Model 2, HR (95% CI)

1.00

1.13 (1.03–1.25)

1.14 (1.04–1.26)

1.31 (1.19–1.44)

1.09 (1.06–1.13)

 < 0.001

Model 3, HR (95% CI)

1.00

1.13 (1.03–1.25)

1.14 (1.04–1.26)

1.31 (1.19–1.44)

1.09 (1.06–1.13)

 < 0.001

  1. TyG triglyceride-glucose, HR hazard ratio, CI confidence interval, SD standard deviation, TyG-WC triglyceride glucose-waist circumference, TyG-WHtR triglyceride glucose-waist to height ratio, TyG-WHR triglyceride glucose-waist to hip ratio, TyG-BMI triglyceride glucose-body mass index
  2. Model 1: adjusted for age, race, and Townsend Deprivation Index
  3. Model 2: further adjusted for walking, education, smoking, drinking, family history of breast cancer, history of cardiovascular diseases, screening, contraceptives, age at menarche, number of live births, hormone replacement therapy, age at menopause
  4. Model 3: further adjusted for diabetes, fasting time, cholesterol, high-density cholesterol